Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up ...
Abstract Background First Nations Peoples of Australia are disproportionally affected by hepatitis C (HCV) infection. Through a prospective study we evaluated the outcome of direct-acting antiviral (DAA) therapy among First Nations Peoples with HCV infection. Methods Adults who initiated DAA therapy...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article in Journal/Newspaper |
Language: | unknown |
Published: |
figshare
2022
|
Subjects: | |
Online Access: | https://dx.doi.org/10.6084/m9.figshare.c.6092149 https://springernature.figshare.com/collections/Hepatitis_C_treatment_outcomes_for_Australian_First_Nations_Peoples_equivalent_SVR_rate_but_higher_rates_of_loss_to_follow-up/6092149 |
id |
ftdatacite:10.6084/m9.figshare.c.6092149 |
---|---|
record_format |
openpolar |
spelling |
ftdatacite:10.6084/m9.figshare.c.6092149 2024-04-28T08:18:50+00:00 Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up ... Clark, Paul J. Valery, Patricia C. Ward, James Strasser, Simone I. Weltman, Martin Thompson, Alexander Levy, Miriam T. Leggett, Barbara Zekry, Amany Rong, Julian Angus, Peter George, Jacob Bollipo, Steven McGarity, Bruce Sievert, William Macquillan, Gerry Tse, Edmund Nicoll, Amanda Wade, Amanda Chu, Geoff Harding, Damian Cheng, Wendy Farrell, Geoff Roberts, Stuart K. 2022 https://dx.doi.org/10.6084/m9.figshare.c.6092149 https://springernature.figshare.com/collections/Hepatitis_C_treatment_outcomes_for_Australian_First_Nations_Peoples_equivalent_SVR_rate_but_higher_rates_of_loss_to_follow-up/6092149 unknown figshare Creative Commons Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/legalcode cc-by-4.0 Medicine Science Policy Mental Health Infectious Diseases FOS Health sciences Collection article 2022 ftdatacite https://doi.org/10.6084/m9.figshare.c.6092149 2024-04-02T12:06:10Z Abstract Background First Nations Peoples of Australia are disproportionally affected by hepatitis C (HCV) infection. Through a prospective study we evaluated the outcome of direct-acting antiviral (DAA) therapy among First Nations Peoples with HCV infection. Methods Adults who initiated DAA therapy at one of 26 hospitals across Australia, 2016–2019 were included in the study. Clinical data were obtained from medical records and the Pharmaceutical and Medicare Benefits Schemes. Outcomes included sustained virologic response (SVR) and loss to follow-up (LTFU). A multivariable analysis assessed factors associated with LTFU. Results Compared to non-Indigenous Australians (n = 3206), First Nations Peoples (n = 89) were younger (p < 0.001), morel likely to reside in most disadvantaged (p = 0.002) and in regional/remote areas (p < 0.001), and had similar liver disease severity. Medicines for mental health conditions were most commonly dispensed among First Nations Peoples (55.2% vs. 42.8%; p = 0.022). Of ... Article in Journal/Newspaper First Nations DataCite Metadata Store (German National Library of Science and Technology) |
institution |
Open Polar |
collection |
DataCite Metadata Store (German National Library of Science and Technology) |
op_collection_id |
ftdatacite |
language |
unknown |
topic |
Medicine Science Policy Mental Health Infectious Diseases FOS Health sciences |
spellingShingle |
Medicine Science Policy Mental Health Infectious Diseases FOS Health sciences Clark, Paul J. Valery, Patricia C. Ward, James Strasser, Simone I. Weltman, Martin Thompson, Alexander Levy, Miriam T. Leggett, Barbara Zekry, Amany Rong, Julian Angus, Peter George, Jacob Bollipo, Steven McGarity, Bruce Sievert, William Macquillan, Gerry Tse, Edmund Nicoll, Amanda Wade, Amanda Chu, Geoff Harding, Damian Cheng, Wendy Farrell, Geoff Roberts, Stuart K. Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up ... |
topic_facet |
Medicine Science Policy Mental Health Infectious Diseases FOS Health sciences |
description |
Abstract Background First Nations Peoples of Australia are disproportionally affected by hepatitis C (HCV) infection. Through a prospective study we evaluated the outcome of direct-acting antiviral (DAA) therapy among First Nations Peoples with HCV infection. Methods Adults who initiated DAA therapy at one of 26 hospitals across Australia, 2016–2019 were included in the study. Clinical data were obtained from medical records and the Pharmaceutical and Medicare Benefits Schemes. Outcomes included sustained virologic response (SVR) and loss to follow-up (LTFU). A multivariable analysis assessed factors associated with LTFU. Results Compared to non-Indigenous Australians (n = 3206), First Nations Peoples (n = 89) were younger (p < 0.001), morel likely to reside in most disadvantaged (p = 0.002) and in regional/remote areas (p < 0.001), and had similar liver disease severity. Medicines for mental health conditions were most commonly dispensed among First Nations Peoples (55.2% vs. 42.8%; p = 0.022). Of ... |
format |
Article in Journal/Newspaper |
author |
Clark, Paul J. Valery, Patricia C. Ward, James Strasser, Simone I. Weltman, Martin Thompson, Alexander Levy, Miriam T. Leggett, Barbara Zekry, Amany Rong, Julian Angus, Peter George, Jacob Bollipo, Steven McGarity, Bruce Sievert, William Macquillan, Gerry Tse, Edmund Nicoll, Amanda Wade, Amanda Chu, Geoff Harding, Damian Cheng, Wendy Farrell, Geoff Roberts, Stuart K. |
author_facet |
Clark, Paul J. Valery, Patricia C. Ward, James Strasser, Simone I. Weltman, Martin Thompson, Alexander Levy, Miriam T. Leggett, Barbara Zekry, Amany Rong, Julian Angus, Peter George, Jacob Bollipo, Steven McGarity, Bruce Sievert, William Macquillan, Gerry Tse, Edmund Nicoll, Amanda Wade, Amanda Chu, Geoff Harding, Damian Cheng, Wendy Farrell, Geoff Roberts, Stuart K. |
author_sort |
Clark, Paul J. |
title |
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up ... |
title_short |
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up ... |
title_full |
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up ... |
title_fullStr |
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up ... |
title_full_unstemmed |
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up ... |
title_sort |
hepatitis c treatment outcomes for australian first nations peoples: equivalent svr rate but higher rates of loss to follow-up ... |
publisher |
figshare |
publishDate |
2022 |
url |
https://dx.doi.org/10.6084/m9.figshare.c.6092149 https://springernature.figshare.com/collections/Hepatitis_C_treatment_outcomes_for_Australian_First_Nations_Peoples_equivalent_SVR_rate_but_higher_rates_of_loss_to_follow-up/6092149 |
genre |
First Nations |
genre_facet |
First Nations |
op_rights |
Creative Commons Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/legalcode cc-by-4.0 |
op_doi |
https://doi.org/10.6084/m9.figshare.c.6092149 |
_version_ |
1797582625002487808 |